Latham & Watkins Advised Boston Scientific In Acquisition Of Valencia Technologies Corporation

Latham & Watkins Advised Boston Scientific in Acquisition of Valencia Technologies Corporation

Latham & Watkins advised Boston Scientific Corporation (NYSE: BSX) has announced it has entered into a definitive agreement to acquire Valencia Technologies Corporation, a privately held medical technology company focused on the development and commercialization of innovative solutions to treat bladder dysfunction. The company's eCoin® System is an implantable tibial nerve stimulation (ITNS) device for the treatment of urge urinary incontinence (UUI), a common symptom of overactive bladder (OAB). Boston Scientific expects to complete the acquisition in the first half of 2026, subject to customary closing conditions.

The Latham & Watkins LLP deal team led by Boston Julie Scallen (Partner), and Boston Cory Lewis (Counsel), with Sue Yeon Kim (Associate), Cherrie Wang (Associate), and Emma Bowler (Associate). Advice was also provided on tax matters by Washington, D.C. Nicholas DeNovio (Partner), and Abigail Friedman (Partner), on intellectual property matters by New York Eliot Choy (Counsel), with Arun Mohan (Associate), on litigation matters by Boston Nathan Sandals (Partner), with assistance from Zach Edelman, on healthcare matters by Bay Area Heather Deixler (Partner), and Betty Pang (Partner), Washington, D.C. Chad Jennings (Counsel), and Zac Alpert (Associate), and on employment matters by Washington, D.C. Nikhil Kumar (Partner), and New York Sandra Benjamin (Counsel), with Christina Schrantz (Associate).

Click to know more about Latham & Watkins

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.